Skip to content
Open access

Tumor-cell TOP2A contributes to ochratoxin A-enhanced hepatocellular carcinoma progression and impaired CD8⁺ T-cell responses.

Nov 2026 · Ecotoxicology and Environmental Safety · Vol 326, pp. 120985 · 0 citations · 46 references
Medicine

Abstract

Ochratoxin A (OTA) is a widespread foodborne mycotoxin with hepatotoxic and immunotoxic effects, but its role in hepatocellular carcinoma (HCC) progression and antitumor immunity remains unclear. Here, we integrated network toxicology, bulk and single-cell transcriptomics, machine learning, molecular interaction assays, and experimental validation to identify key molecular factors associated with OTA-enhanced HCC progression. DNA topoisomerase II alpha (TOP2A) was prioritized, and direct OTA-TOP2A interaction was supported by surface plasmon resonance and drug affinity-responsive target stability assays. OTA increased TOP2A expression, promoted HCC-cell proliferation, migration, and invasion, and suppressed apoptosis. TOP2A knockdown attenuated these effects, whereas shRNA-resistant TOP2A rescue substantially restored the malignant phenotypes. In HCC cell-T-cell coculture, OTA-pretreated tumor cells impaired CD8⁺ T-cell responses, as indicated by reduced CD69, granzyme B, and IFN-γ expression, increased PD-1 expression, and enhanced T-cell apoptosis. These effects were alleviated by TOP2A knockdown, and this alleviation was reversed by TOP2A rescue. CCK-8 and LDH release assays further showed that OTA pretreatment reduced CD8⁺ T-cell-associated cytotoxicity against Hep3B cells, whereas tumor-cell TOP2A knockdown attenuated this reduction and shRNA-resistant TOP2A rescue reversed the protective effect of knockdown. Direct OTA treatment of T cells alone did not produce comparable changes in the measured endpoints. Integrative transcriptomic analysis further revealed opposing metabolic programs between OTA exposure and TOP2A knockdown. Notably, glycolysis-related gene sets were positively enriched following OTA treatment but negatively enriched after TOP2A knockdown, accompanied by reciprocal regulation of glycolysis- and tumor microenvironment-associated genes, including LDHA, SLC2A1, PGK1, CA9, and SERPINE1. In an immunocompetent orthotopic HCC model, OTA promoted tumor growth and proliferative activity and reduced intratumoral CD8⁺ T-cell infiltration, whereas tumor-cell Top2a knockdown attenuated these effects. Collectively, these findings provide gene-specific evidence for a functional contribution of tumor-cell TOP2A to OTA-enhanced HCC progression and impaired CD8⁺ T-cell responses, including reduced antitumor cytotoxicity, while TOP2A-associated glycolytic alterations represent a potential downstream feature that requires further functional validation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.